These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 25234313)

  • 21. Inhibition and recovery of rat hepatic glutathione S-transferase zeta and alteration of tyrosine metabolism following dichloroacetate exposure and withdrawal.
    Guo X; Dixit V; Liu H; Shroads AL; Henderson GN; James MO; Stacpoole PW
    Drug Metab Dispos; 2006 Jan; 34(1):36-42. PubMed ID: 16199472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD.
    Park F; Sweeney WE; Jia G; Akbulut T; Mueller B; Falck JR; Birudaraju S; Roman RJ; Avner ED
    Am J Physiol Renal Physiol; 2009 Mar; 296(3):F575-82. PubMed ID: 19129252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of hydration in rats and mice with polycystic kidney disease.
    Hopp K; Wang X; Ye H; Irazabal MV; Harris PC; Torres VE
    Am J Physiol Renal Physiol; 2015 Feb; 308(3):F261-6. PubMed ID: 25503729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease.
    Gattone VH; Maser RL; Tian C; Rosenberg JM; Branden MG
    Dev Genet; 1999; 24(3-4):309-18. PubMed ID: 10322639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New rat model that phenotypically resembles autosomal recessive polycystic kidney disease.
    Nauta J; Goedbloed MA; Herck HV; Hesselink DA; Visser P; Willemsen R; Dokkum RPEV; Wright CJ; Guay-Woodford LM
    J Am Soc Nephrol; 2000 Dec; 11(12):2272-2284. PubMed ID: 11095650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo MRI measurements of tumor growth induced by dichloroacetate: implications for mode of action.
    Miller JH; Minard K; Wind RA; Orner GA; Sasser LB; Bull RJ
    Toxicology; 2000 Apr; 145(2-3):115-25. PubMed ID: 10771136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary Level of Liver-Type Fatty Acid Binding Protein Reflects the Degree of Tubulointerstitial Damage in Polycystic Kidney Disease.
    Watanabe S; Ichikawa D; Sugaya T; Ohata K; Inoue K; Hoshino S; Kimura K; Shibagaki Y; Kamijo-Ikemori A
    Kidney Blood Press Res; 2018; 43(6):1716-1729. PubMed ID: 30472704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.
    Gattone VH; Siqueira TM; Powell CR; Trambaugh CM; Lingeman JE; Shalhav AL
    Exp Biol Med (Maywood); 2008 Aug; 233(8):952-7. PubMed ID: 18480417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib.
    Sato Y; Harada K; Furubo S; Kizawa K; Sanzen T; Yasoshima M; Ozaki S; Isse K; Sasaki M; Nakanuma Y
    Am J Pathol; 2006 Oct; 169(4):1238-50. PubMed ID: 17003482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycystic kidney rat is a novel animal model of Caroli's disease associated with congenital hepatic fibrosis.
    Sanzen T; Harada K; Yasoshima M; Kawamura Y; Ishibashi M; Nakanuma Y
    Am J Pathol; 2001 May; 158(5):1605-12. PubMed ID: 11337358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo genotoxicity of dichloroacetic acid: evaluation with the mouse peripheral blood micronucleus assay and the single cell gel assay.
    Fuscoe JC; Afshari AJ; George MH; DeAngelo AB; Tice RR; Salman T; Allen JW
    Environ Mol Mutagen; 1996; 27(1):1-9. PubMed ID: 8625942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue culture correlational study of genetic cholangiopathy of autosomal recessive polycystic kidney disease.
    Nakanuma Y; Sato Y; Harada K
    Methods Mol Biol; 2013; 945():303-18. PubMed ID: 23097114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease.
    Tao Y; Kim J; Schrier RW; Edelstein CL
    J Am Soc Nephrol; 2005 Jan; 16(1):46-51. PubMed ID: 15563559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased water intake reduces long-term renal and cardiovascular disease progression in experimental polycystic kidney disease.
    Sagar PS; Zhang J; Luciuk M; Mannix C; Wong ATY; Rangan GK
    PLoS One; 2019; 14(1):e0209186. PubMed ID: 30601830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of P2X
    Xu B; Nikolaienko O; Levchenko V; Choubey AS; Isaeva E; Staruschenko A; Palygin O
    Physiol Rep; 2022 Nov; 10(21):e15510. PubMed ID: 36353932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics and effects of dichloroacetic acid in rainbow trout.
    Fitzsimmons PN; Hoffman AD; Lien GJ; Hammermeister DE; Nichols JW
    Aquat Toxicol; 2009 Sep; 94(3):186-94. PubMed ID: 19656582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat.
    Wang X; Gattone V; Harris PC; Torres VE
    J Am Soc Nephrol; 2005 Apr; 16(4):846-51. PubMed ID: 15728778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice.
    Bull RJ; Sasser LB; Lei XC
    Toxicology; 2004 Jul; 199(2-3):169-83. PubMed ID: 15147791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.